Health Care
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Latest
Report
The United States is currently grappling with a nursing shortage that is causing a ripple effect of rising health care costs and lower quality of life across the country.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Latest Content
This statement is issued by the signatory organisations listed below and not by the Global Business Coalition, as an organisation
WASHINGTON, D.C. — U.S. Chamber of Commerce President and CEO Thomas J. Donohue today released the following statement applauding House and Senate passage of legislation to address the opioid epidemic:
The U.S. Chamber of Commerce strongly supports the bipartisan H.R. 6, the “Opioid Crisis Response Act of 2018.”
TO THE MEMBERS OF THE U.S. HOUSE OF REPRESENTATIVES: The U.S. Chamber of Commerce strongly supports the bipartisan H.R. 6, the “Opioid Crisis Response Act of 2018.” The Chamber will consider including votes related to this bill in our annual How They Voted scorecard. The opioid epidemic is ravaging families and destroying the lives of thousands each year, and it is crippling communities’ and employers’ efforts to staff workforce needs, create new jobs, and expand commerce.
This letter was sent to both houses of the U.S. Congress, opposing the inclusion of an end-stage renal disease (ESRD) provision in H.R. 6, the opioid package.
There's no time to delay as opioids are claiming more lives daily, and communities are being undermined.
This Key Vote letter was sent to the U.S. House of Representatives supporting H.R. 3798, “the Save American Workers Act.”
This letter was sent to the U.S. Senate on H.R. 6, the "Opioid Crisis Response Act of 2018."
Many Americans will face a $20.3 billion tax hike starting in January 2020 if nothing is done.
This letter was sent to Sen. Rob Portman in support of S. 3057, the "Synthetic Trafficking and Overdose Prevention Act of 2018."
